TY - JOUR
T1 - EUS-Through-The-needle microbiopsy forceps in pancreatic cystic lesions
T2 - A systematic review
AU - Balaban, Vasile
AU - Cazacu, Irina
AU - Pinte, Larisa
AU - Jinga, Mariana
AU - Bhutani, Manoop
AU - Saftoiu, Adrian
N1 - Publisher Copyright:
© 2021 Spring Media. All rights reserved.
PY - 2021/1/1
Y1 - 2021/1/1
N2 - Pancreatic cystic lesions (PCLs) are being increasingly encountered in clinical practice, and sometimes, they can represent a diagnostic challenge. Recently, a through-The-needle micro forceps biopsy (MFB) device was introduced in the endosonography practice to facilitate EUS-guided sampling of PCLs. The aim was to perform a systematic review of studies evaluating the technical aspects, safety, and efficacy of the EUS-guided MFB for PCLs. A literature search was performed in three major databases, PubMed, Embase, and Web of Science in September 2019 using the search terms: 'through-The-needle,' 'biopsy forceps,' 'microforceps,' 'endoscopic ultrasound,' and 'endosonography.' Case reports and case series with <10 patients were excluded from the analysis. Altogether nine studies reporting on 463 patients were included in our systematic review. The mean age of the patients was 68.3 years, with a slight female predominance (60.9%). Most of the cysts were located in the body/tail of the pancreas (61.2%), with an overall mean size of 33 mm. The technical success of EUS-guided MFB was reported in 98.5%. The tissue acquisition yield reported was 88.2%, and the diagnostic accuracy was 68.6%. Adverse events were reported in 9.7%. EUS-guided MFB is technically feasible, safe, and has a high diagnostic accuracy for PCLs.
AB - Pancreatic cystic lesions (PCLs) are being increasingly encountered in clinical practice, and sometimes, they can represent a diagnostic challenge. Recently, a through-The-needle micro forceps biopsy (MFB) device was introduced in the endosonography practice to facilitate EUS-guided sampling of PCLs. The aim was to perform a systematic review of studies evaluating the technical aspects, safety, and efficacy of the EUS-guided MFB for PCLs. A literature search was performed in three major databases, PubMed, Embase, and Web of Science in September 2019 using the search terms: 'through-The-needle,' 'biopsy forceps,' 'microforceps,' 'endoscopic ultrasound,' and 'endosonography.' Case reports and case series with <10 patients were excluded from the analysis. Altogether nine studies reporting on 463 patients were included in our systematic review. The mean age of the patients was 68.3 years, with a slight female predominance (60.9%). Most of the cysts were located in the body/tail of the pancreas (61.2%), with an overall mean size of 33 mm. The technical success of EUS-guided MFB was reported in 98.5%. The tissue acquisition yield reported was 88.2%, and the diagnostic accuracy was 68.6%. Adverse events were reported in 9.7%. EUS-guided MFB is technically feasible, safe, and has a high diagnostic accuracy for PCLs.
KW - EUS
KW - diagnostic accuracy
KW - microbiopsy forceps
KW - pancreatic cyst
UR - http://www.scopus.com/inward/record.url?scp=85101364589&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85101364589&partnerID=8YFLogxK
U2 - 10.4103/eus.eus_23_20
DO - 10.4103/eus.eus_23_20
M3 - Review article
C2 - 32611848
AN - SCOPUS:85101364589
SN - 2303-9027
VL - 10
SP - 19
EP - 24
JO - Endoscopic Ultrasound
JF - Endoscopic Ultrasound
IS - 1
ER -